Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.14 - $0.23 $35,301 - $57,995
-252,154 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$0.22 - $0.47 $52,800 - $112,800
240,000 Added 1974.66%
252,154 $56,000
Q3 2021

Nov 15, 2021

SELL
$0.8 - $1.12 $614 - $860
-768 Reduced 5.94%
12,154 $11,000
Q4 2020

Feb 12, 2021

BUY
$1.61 - $2.23 $20,804 - $28,816
12,922 New
12,922 $25,000
Q3 2020

Nov 16, 2020

SELL
$1.71 - $2.51 $72,652 - $106,642
-42,487 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$1.77 - $4.23 $75,201 - $179,720
42,487 New
42,487 $94,000

About SOLENO THERAPEUTICS INC


  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $362M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.